APA (7th ed.) Citation

Donglai Chen, Fuquan Zhang, Jinhui Wang, Hua He, Shanzhou Duan, Rongying Zhu, . . . Yongbing Chen. (2018). Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Donglai Chen, Fuquan Zhang, Jinhui Wang, Hua He, Shanzhou Duan, Rongying Zhu, Chang Chen, Lichen Yin, and Yongbing Chen. Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway. Frontiers Media S.A., 2018.

MLA (9th ed.) Citation

Donglai Chen, et al. Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway. Frontiers Media S.A., 2018.